Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 7Melanoma 4Colitis 3Carcinoma, Non-Small-Cell Lung 3Urogenital Neoplasms 2Lung Neoplasms 2Inflammatory Bowel Diseases 2Inflammation 2Fatigue 2Depressive Disorder, Major 2Depression 2Colitis, Ulcerative 2Vasculitis 1Takayasu Arteritis 1Syndrome 1Stroke 1Stevens-Johnson Syndrome 1Spondylitis, Ankylosing 1Skin Neoplasms 1Psoriasis 1Precancerous Conditions 1Pemphigoid, Benign Mucous Membrane 1Infections 1Hypertension 1Hepatitis C 1Hematologic Neoplasms 1Graft vs Host Disease 1Drug-Related Side Effects and Adverse Reactions 1Depressive Disorder, Treatment-Resistant 1Cytokine Release Syndrome 1

Interventions

Infliximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pemphigoid, Benign Mucous Membrane × Infliximab × Clear all
NCT02126020 2017-04-07

Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

Massachusetts Eye and Ear Infirmary

Phase 1/2 Withdrawn

Pemphigoid, Benign Mucous Membrane, Stevens-Johnson Syndrome, Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡